Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 27

Results: 11

Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3908, doi. 10.1038/onc.2010.143

By:

Guo, X.;
Liu, W.;
Pan, Y.;
Ni, P.;
Ji, J.;
Guo, L.;
Zhang, J.;
Wu, J.;
Jiang, J.;
Chen, X.;
Cai, Q.;
Li, J.;
Gu, Q.;
Liu, B.;
Zhu, Z.;
Yu, Y.

Publication type:

Article

The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3977, doi. 10.1038/onc.2010.144

By:

Liu, P.-S.;
Jong, T.-H.;
Maa, M.-C.;
Leu, T.-H.

Publication type:

Article

p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3942, doi. 10.1038/onc.2010.145

By:

Hecker, R. M.;
Amstutz, R. A.;
Wachtel, M.;
Walter, D.;
Niggli, F. K.;
Schäfer, B. W.

Publication type:

Article

The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3990, doi. 10.1038/onc.2010.137

By:

Kim, M.;
Williamson, C. T.;
Prudhomme, J.;
Bebb, D. G.;
Riabowol, K.;
Lee, P. W. K.;
Lees-Miller, S. P.;
Mori, Y.;
Rahman, M. M.;
McFadden, G.;
Johnston, R. N.

Publication type:

Article

DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3953, doi. 10.1038/onc.2010.140

By:

Brem, R.;
Li, F.;
Montaner, B.;
Reelfs, O.;
Karran, P.

Publication type:

Article

Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3873, doi. 10.1038/onc.2010.141

By:

Shrestha-Bhattarai, T.;
Rangnekar, V. M.

Publication type:

Article

Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3964, doi. 10.1038/onc.2010.146

By:

Favre, C.;
Zhdanov, A.;
Leahy, M.;
Papkovsky, D.;
O'Connor, R.

Publication type:

Article

A novel interaction between HER2/neu and cyclin E in breast cancer.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3896, doi. 10.1038/onc.2010.151

By:

Mittendorf, E. A.;
Liu, Y.;
Tucker, S. L.;
McKenzie, T.;
Qiao, N.;
Akli, S.;
Biernacka, A.;
Meijer, L.;
Keyomarsi, K.;
Hunt, K. K.

Publication type:

Article

PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3881, doi. 10.1038/onc.2010.153

By:

Bobrovnikova-Marjon, E.;
Grigoriadou, C.;
Pytel, D.;
Zhang, F.;
Ye, J.;
Koumenis, C.;
Cavener, D.;
Diehl, J. A.

Publication type:

Article

Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3921, doi. 10.1038/onc.2010.158

By:

Santhanam, A. N.;
Baker, A. R.;
Hegamyer, G.;
Kirschmann, D. A.;
Colburn, N. H.

Publication type:

Article

A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A.

Published in:

Oncogene, 2010, v. 29, n. 27, p. 3933, doi. 10.1038/onc.2010.161

By:

Shouse, G. P.;
Nobumori, Y.;
Liu, X.

Publication type:

Article